Characterization of a BMS4 81174-resistant human bladder cancer cell line
1997

Study of BMS-181174 Resistance in Bladder Cancer Cells

publication Evidence: moderate

Author Information

Author(s): H Xia, RJ Bleicher, X Hu, SK Srivastava, V Gupta, HA Zaren, SV Singh

Primary Institution: Cancer Research Laboratory, Mercy Cancer Institute, Mercy Hospital of Pittsburgh

Hypothesis

What mechanisms contribute to cellular resistance to BMS-181174 in a human bladder cancer cell line?

Conclusion

The study suggests that reduced DNA interstrand cross-link formation may be responsible for the resistance of the J82/BMS cell line to BMS-181174.

Supporting Evidence

  • The J82/BMS cell line required a 2.6-fold higher concentration of BMS-181174 to achieve the same level of cell death as the parental J82 cells.
  • The J82/BMS cell line showed collateral sensitivity to 5-fluorouracil but was more resistant to several other drugs.
  • Lower activities of NADPH cytochrome P450 reductase and DT-diaphorase were observed in the J82/BMS cell line compared to J82.

Takeaway

Researchers created a special bladder cancer cell line that doesn't respond well to a new drug, and they think this is because the drug doesn't damage the DNA as much in these cells.

Methodology

The study involved creating a resistant cell line by exposing parental cells to increasing concentrations of BMS-181174 over 17 months and assessing drug sensitivity through colony formation assays.

Limitations

The exact mechanism of reduced DNA interstrand cross-link formation in the resistant cell line remains unclear.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication